MMP9 and hypertrophy: In agreement with this concept, SalA, as a novel MMP-9 inhibitor, ameliorates cardiac fibrosis and hypertrophy in SHR, indicating MMP-9 inhibitor is promising in the treatment of hypertensive fibrosis.